• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of therapeutic concept targeting homomultimerized mutant CALR

Research Project

Project/Area Number 19K08848
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 54010:Hematology and medical oncology-related
Research InstitutionJuntendo University

Principal Investigator

ARAKI MARITO  順天堂大学, 大学院医学研究科, 客員教授 (80613843)

Co-Investigator(Kenkyū-buntansha) 小松 則夫  順天堂大学, 医学部, 特任教授 (50186798)
Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords骨髄増殖性腫瘍 / calreticulin / トロンボポエチン / JAK2 / 分子シャペロン / 受容体 / 2量体 / カルレティキュリン / MPL
Outline of Research at the Start

本研究では、変異型CALR上においてホモ多量体化を担っているドメインを同定し、質量分析やX線結晶構造解析により得られたホモ多量体化ドメインにおいて、多量体化を制御している翻訳後修飾を明らかにする。続いて、このような翻訳後修飾による変異型CALRの多量体化を、RNA干渉法あるいは阻害剤により抑制することで、変異型CALRによる細胞の腫瘍性増殖が抑制できることを示す。最後に、患者細胞や動物モデルにおいて、変異型CALRの多量体化を標的として治療概念を証明する。

Outline of Final Research Achievements

We studied an oncogenic domain that is generated by the frameshift mutation on the carboxyl-terminal of mutant CALR, a causal factor of Philadelphia-negative myelproliferative neoplasms. As a result, we found a new intramolecular interaction mediated by this domain that does not exist in wild-type CALR, identified amino acid residues involved in the interaction, and clarified the significance of the interaction in the oncogenic capacity of mutnat CALR.

Academic Significance and Societal Importance of the Research Achievements

本研究により、変異型CALRに腫瘍原性を付与するドメインの有する機能が明らになったことから、CALR遺伝子変異を有するMPN患者に対する有効な治療薬の開発に資する情報が取得できたことは大変意義深いと考えられる。さらに、変異型分子シャペロンによる受容体活性化という、生物学的にユニークな現象の分子メカニズムの一端が明らかにされたことから、この知見に基づいて、これまで未知となっている生命現象の解明が期待される。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (45 results)

All 2021 2020 2019

All Journal Article (14 results) (of which Peer Reviewed: 11 results,  Open Access: 5 results) Presentation (27 results) (of which Int'l Joint Research: 7 results,  Invited: 4 results) Patent(Industrial Property Rights) (4 results) (of which Overseas: 3 results)

  • [Journal Article] MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations2021

    • Author(s)
      Yasuda Shunichiro、Aoyama Satoru、Yoshimoto Ryoto、Li Huixin、Watanabe Daisuke、Akiyama Hiroki、Yamamoto Kouhei、Fujiwara Takeo、Najima Yuho、Doki Noriko、Sakaida Emiko、Edahiro Yoko、Imai Misa、Araki Marito、Komatsu Norio、Miura Osamu、Kawamata Norihiko
    • Journal Title

      International Journal of Hematology

      Volume: 114 Issue: 4 Pages: 424-440

    • DOI

      10.1007/s12185-021-03180-0

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia2021

    • Author(s)
      Inano Tadaaki、Araki Marito、Morishita Soji、Imai Misa、Kihara Yoshihiko、Okuda Maho、Yang Yinjie、Ito Masafumi、Osaga Satoshi、Mano Hiroyuki、Edahiro Yoko、Ochiai Tomonori、Misawa Kyohei、Fukuda Yasutaka、Ando Jun、Komatsu Norio
    • Journal Title

      Scientific Reports

      Volume: 11 Issue: 1 Pages: 17702-17702

    • DOI

      10.1038/s41598-021-97106-9

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] MPNにおけるcalreticulin遺伝子変異の意義2021

    • Author(s)
      増渕菜弥、荒木真理人、小松則夫
    • Journal Title

      血液内科

      Volume: 82 Pages: 339-346

    • Related Report
      2020 Research-status Report
  • [Journal Article] Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin2020

    • Author(s)
      Edahiro Yoko、Araki Marito、Komatsu Norio
    • Journal Title

      Cancer Science

      Volume: 111 Issue: 8 Pages: 2682-2688

    • DOI

      10.1111/cas.14503

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome?negative myeloproliferative neoplasms2020

    • Author(s)
      Morishita Soji、Yasuda Hajime、Yamawaki Saya、Kawaji Hideya、Itoh Masayoshi、Edahiro Yoko、Imai Misa、Kogo Yasushi、Tsuneda Satoshi、Ohsaka Akimichi、Hayashizaki Yoshihide、Ito Masafumi、Araki Marito、Komatsu Norio
    • Journal Title

      Cancer Science

      Volume: 112 Issue: 2 Pages: 884-892

    • DOI

      10.1111/cas.14763

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Thrombocytosis caused by abnormal molecular chaperone2020

    • Author(s)
      ARAKI Marito
    • Journal Title

      Japanese Journal of Thrombosis and Hemostasis

      Volume: 31 Issue: 5 Pages: 491-497

    • DOI

      10.2491/jjsth.31.491

    • NAID

      130007928076

    • ISSN
      0915-7441, 1880-8808
    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] 変異型calreticulinによる骨髄増殖性腫瘍発症の分子基盤2020

    • Author(s)
      荒木 真理人
    • Journal Title

      臨床血液

      Volume: 61 Pages: 937-944

    • NAID

      130007897793

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface2019

    • Author(s)
      Masubuchi Nami、Araki Marito、Yang Yinjie、Hayashi Erina、Imai Misa、Edahiro Yoko、Hironaka Yumi、Mizukami Yoshihisa、Kihara Yoshihiko、Takei Hiraku、Nudejima Mai、Koike Masato、Ohsaka Akimichi、Komatsu Norio
    • Journal Title

      Leukemia

      Volume: 34 Issue: 2 Pages: 499-509

    • DOI

      10.1038/s41375-019-0564-z

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] The role of calreticulin mutations in myeloproliferative neoplasms2019

    • Author(s)
      Araki Marito、Komatsu Norio
    • Journal Title

      International Journal of Hematology

      Volume: 111 Issue: 2 Pages: 200-205

    • DOI

      10.1007/s12185-019-02800-0

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera2019

    • Author(s)
      Inano, T. Araki, M. Morishita, S. Imai, M. Yasuda, H. Nitta, H. Ito, M. Edahiro, Y. Ochiai, T. Misawa, K. Fukuda, Y. Ohsaka, A. Komatsu, N.
    • Journal Title

      British Journal of Haematology

      Volume: 187 Issue: 1

    • DOI

      10.1111/bjh.16146

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy2019

    • Author(s)
      Fukuda Yasutaka、Araki Marito、Yamamoto Kouji、Morishita Soji、Inano Tadaaki、Misawa Kyohei、Ochiai Tomonori、Edahiro Yoko、Imai Misa、Yasuda Hajime、Gotoh Akihiko、Ohsaka Akimichi、Komatsu Norio
    • Journal Title

      Haematologica

      Volume: 印刷中 Issue: 11 Pages: e506-e509

    • DOI

      10.3324/haematol.2018.208876

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan2019

    • Author(s)
      Edahiro Yoko、Araki Marito、Inano Tadaaki、Ito Masafumi、Morishita Soji、Misawa Kyohei、Fukuda Yasutaka、Imai Misa、Ohsaka Akimichi、Komatsu Norio
    • Journal Title

      European Journal of Haematology

      Volume: 00 Issue: 6 Pages: 1-5

    • DOI

      10.1111/ejh.13236

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] MPNのゲノム解析研究の進歩2019

    • Author(s)
      奥田真帆、荒木真理人、小松則夫
    • Journal Title

      血液内科

      Volume: 79 Pages: 556-564

    • Related Report
      2019 Research-status Report
  • [Journal Article] 骨髄増殖性腫瘍の遺伝子異常2019

    • Author(s)
      荒木真理人、森下総司、小松則夫
    • Journal Title

      臨床検査

      Volume: 63 Pages: 790-796

    • Related Report
      2019 Research-status Report
  • [Presentation] On the mechanism of sugar-chain mediated activation of thrombopoietin receptor (MPL)2021

    • Author(s)
      Hiromi Watari, Hiromu Kageyama, Hiroya Nakajima, Kako Onodera, PJ Foces, Nami Masubuchi, Takashi Matsui, Yoshio Kodera, Tomohisa Ogawa, Makoto Hirayama, Kanji Hori, Takeshi Yokoyama, Douglas Freymann, Norio Komatsu, Marito Araki, Yoshikazu Tanaka, Ryuichi Sakai
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Therapeutic Potential of an Antibody Targeting the Cleaved Form of Mutant Calreticulin in Myeloproliferative Neoplasms2021

    • Author(s)
      Marito Araki
    • Organizer
      MPN Asia 2021 - the International Symposium on Myeloproliferative Neoplasms
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Distributions of typical non-driver mutations in essential thrombocythemia and polycythemia vera2021

    • Author(s)
      Soji Morishita, Yoko Edahiro, Yoshinori Hashimoto, Shuichi Shirane, Tomonori Ochiai, Kyohei Misawa, Tadaaki Inano, Yasutaka Fukuda, Yosuke Mori, Chiho Furuya, Marito Araki, Jun Ando, Norio Komatsu
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 海洋天然物由来の新規生理活性タンパク質の構造機能解析2021

    • Author(s)
      田中良和, 影山大夢, 辺ひろみ, 増渕菜弥, 中島寛也, 小野寺かこ, 松井崇, 小寺義男, 小川智久, 横山武司, 小松則夫, 荒木真理人, 酒井隆一
    • Organizer
      第94回日本生化学会大会
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Presentation] Quantitative measurement of mutant calreticulin in specimens of myeloproliferative neoplasm patients2021

    • Author(s)
      Satoko Ogata, Marito Araki, Yoshihiko Kihara, Maho Okuda, Soji Morishita, Misa Imai, Nami Masubuchi, Yousuke Mori, Yinjie Yang, Syunpei Yoshikawa, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Jun Ando, Norio Komatsu
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Therapeutic potential of an antibody targeting the cleaved form of mutant calreticulin in myeloproliferative neoplasms2020

    • Author(s)
      Kihara Y, Araki M, Imai M, Mori Y, Horino M, Ogata T, Yoshikawa S, Taguchi T, Masubuchi N, Mabuchi Y, Yang Y, Fukuda Y, Morishita S, Suzuki T, Dohmae N, Shimonaka M, Akazawa C, Ohsaka A, Komatsu N.
    • Organizer
      62nd Annual Meeting & Exposition of American Society of Hematology
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] Concomitant occurrence of polyclonal hematopoiesis and cell-autonomous megakaryopoiesis in triple-negative essential thrombocythemia2020

    • Author(s)
      Inano T, Araki M, Morishita S, Imai M, Kihara Y, Okuda M, Ito M, Osaga S, Yang Y, Edahiro Y, Ochiai T, Misawa K, Fukuda Y, Ohsaka A, Komatsu N.
    • Organizer
      62nd Annual Meeting & Exposition of American Society of Hematology
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] CREB3L1 Overexpression Can Reliably Discriminate Ph-MPNs from Reactive Cases2020

    • Author(s)
      Morishita S, Yasuda H, Yamawaki S, Kawaji H, Itoh M, Edahiro Y, Imai M, Kogo Y, Tsuneda S, Akimichi Ohsaka, Hayashizaki Y, Araki M, Komatsu N.
    • Organizer
      62nd Annual Meeting & Exposition of American Society of Hematology
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] MPL Overexpression Induces a High Level of Mutant-Calr/MPL Complex: A Novel Mechanism of Ruxolitinib Resistance in Myeloproliferative Neoplasms with Calr Mutations2020

    • Author(s)
      Yasuda S, Aoyama S, Yoshimoto R, Watanabe D, Akiyama H, Yamamoto K, Fujiwara T, Sakaida E, Edahiro Y, Imai M, Araki M, Komatsu N, Kawamata N.
    • Organizer
      62nd Annual Meeting & Exposition of American Society of Hematology
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] Therapeutic potential of myeloproliferative neoplasms by antibody targeting mutant calreticulin2020

    • Author(s)
      Kihara Y, Araki M, Imai M, Fukuda Y, Mori Y, Taguchi T, Masubuchi N, Mabuchi Y, Yang Y, Mizukami Y, Morishita S, Akazawa C, Ohsaka A, Komatsu N.
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Analysis of behavior of erythropoietin receptor on the cell surface in JAK2 mutant cells2020

    • Author(s)
      Shioiri K, Araki M, Kitazawa S, Masubuchi N, Morishita S, Imai M, Ohsaka A, Komatsu N.
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] CREB3L1 overexpression as a novel diagnostic marker of myeloproliferative neoplasms2020

    • Author(s)
      Morishita S, Yasuda H, Yamawaki S, Kawaji H, Itoh M, Edahiro Y, Imai M, Kogo Y, Tsuneda S, Ohsaka A, Hayashizaki Y, Araki M, Komatsu N.
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Targeting ER stress enhances inhibitory effect of ruxolitinib in mutated-CALR transfected cells2020

    • Author(s)
      Moriyama M, Akahane D, Moriya S, Imai M, Araki M, Komatsu N, Miyazawa K, Gotoh A.
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Overexpression of MPL causes ruxolitinib-resistance in MPN with CALR frame-shift mutations.2020

    • Author(s)
      Yasuda S, Aoyama S, Yoshimoto R, Watanabe D, Yamamoto K, Fujiwara T, Edahiro Y, Imai M, Araki M, Komatsu N, Miura O, Kawamata N.
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Targeting calreticulin neoantigen for the treatment of myeloproliferative neoplasms2020

    • Author(s)
      Araki M, Komatsu N.
    • Organizer
      第79回日本癌学会学術総会
    • Related Report
      2020 Research-status Report
  • [Presentation] 典型的なドライバー遺伝子変異の見いだされない本態性血小板血症の特徴2020

    • Author(s)
      荒木真理人, 稲野資明, 森下総司, 木原慶彦, 奥田真帆, 楊印杰, 今井美沙, 枝廣陽子, 伊藤雅文, 大佐賀智, 落合友則, 三澤恭平, 大坂顯通, 小松則夫.
    • Organizer
      第30回日本サイトメトリー学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] The molecular mechanism underlying the development of myeloproliferative neoplasms by mutant calreticulin2019

    • Author(s)
      Marito Araki
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
    • Invited
  • [Presentation] Oncogenic activation of thrombopoietin receptor by mutant calreticulin on cell surface2019

    • Author(s)
      Marito Araki、Norio Komatsu
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Research-status Report
  • [Presentation] calreticulin変異による骨髄増殖性腫瘍発症の分子メカニズム2019

    • Author(s)
      荒木真理人、楊印杰、増渕菜弥、林英里奈、水上喜久、木原慶彦、今井美沙、弘中由美、橳島麻衣、枝廣陽子、大坂顯通、小松則夫
    • Organizer
      第29回日本サイトメトリー学会学術集会
    • Related Report
      2019 Research-status Report
    • Invited
  • [Presentation] Overexpression of MPL Causes Ruxolitinib-Resistance in Myeloproliferative Neoplasms with Calreticulin Frame-Shift Mutations2019

    • Author(s)
      Shunichiro Yasuda、Satoru Aoyama、Ryoto Yoshimoto、Watanabe Daisuke、Hiroki Akiyama、Yoshihiro Umezawa、Ayako Nogami、Kouhei Yamamoto、Takeo Fujiwara、Yoko Edahiro Marito Araki、Norio Komatsu、Tetsuya Fukuda、Ayako Arai、Osamu Miura、Norihiko Kawamata
    • Organizer
      61th Annual Meeting & Exposition of American Society of Hematology
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Mutations in epigenetic and splicing related genes among Japanese overt and prefibrotic primary myelofibrosis using target seuencing2019

    • Author(s)
      Soji Morishita、Tomonori Ochiai、Kyohei Misawa、Tadaaki Inano、Yasutaka Fukuda、Yasumitsu Kurokawa、Yoko Edahiro、Marito Araki、Akimichi Ohsaka、Norio Komatsu
    • Organizer
      The 10th JSH International Symposium
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Mutant calreticulin interacts with MPL in the secretion pathway for the activation on cell surface.2019

    • Author(s)
      Nami Masubuchi、Marito Araki、Yinjie Yang、Erina Hayashi、Misa Imai、Yoko Edahiro、Yumi Hironaka、Yoshihisa Mizukami、Yoshihiko Kihara、Masato Koike、Akimichi Ohsaka、Norio Komatsu
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] Mutant specific sequence promotes accumulation of mutant CALR in the Golgi apparatus2019

    • Author(s)
      Yoshihisa Mizukami、Marito Araki、Misa Imai、Erina Hayashi、Nami Masubuchi、Yinjie Yang、Yoshihiko Kihara、Yumi Hironaka、Akimichi Ohsaka、Norio Komatsu
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] Distinctive clinical and molecular features in absolute triple-negative essential thrombocythemia2019

    • Author(s)
      Tadaaki Inano、Marito Araki、Soji Morishita、Tomonori Ochiai、Kyohei Misawa、Yasutaka Fukuda、Naoko Midorikawa、Mai Nudejima、Masafumi Ito、Satoshi Osaga、Yoko Edahiro、Misa Imai、Teppei Taguchi、Maho Okuda、Akimichi Ohsaka、Norio Komatsu
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] Establishment of a mouse model for mutant CALR myeloproliferative neoplasms2019

    • Author(s)
      Misa Imai、Yasutaka Fukuda、Teppei Taguchi、Kyohei Misawa、Honglian Tong、Kimi Araki、Motomi Osato、Akimichi Ohsaka、Marito Araki、Norio Komatsu
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 分泌経路における変異型分子シャペロンとサイトカイン受容体の会合による細胞の腫瘍化2019

    • Author(s)
      増渕菜弥、荒木真理人、木原慶彦、楊印杰、今井美沙、水上喜久、林英里奈、弘中由美、竹井拓、枝廣陽子、大坂顯通、小松則夫
    • Organizer
      第29回日本サイトメトリー学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 変異型特異的配列による変異型CALRの細胞内局在の規定2019

    • Author(s)
      水上喜久、荒木真理人、今井美沙、林英里奈、増渕菜弥、楊印杰、木原慶彦、弘中由美、大坂顯通、小松則夫
    • Organizer
      第29回日本サイトメトリー学会学術集会
    • Related Report
      2019 Research-status Report
  • [Patent(Industrial Property Rights)] 抗切断型変異CALR-CD3二重特異性抗体及び医薬組成物2020

    • Inventor(s)
      小松則夫、荒木真理人、木原慶彦、石田陽治、ほか
    • Industrial Property Rights Holder
      小松則夫、荒木真理人、木原慶彦、石田陽治、ほか
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2020-143551
    • Filing Date
      2020
    • Related Report
      2020 Research-status Report
  • [Patent(Industrial Property Rights)] 切断型の変異型Calreticulinに結合する抗体、及び骨髄増殖性腫瘍の診断、予防又は治療薬2020

    • Inventor(s)
      荒木真理人、小松則夫、木原慶彦
    • Industrial Property Rights Holder
      荒木真理人、小松則夫、木原慶彦
    • Industrial Property Rights Type
      特許
    • Filing Date
      2020
    • Related Report
      2020 Research-status Report
    • Overseas
  • [Patent(Industrial Property Rights)] 多血症治療薬2020

    • Inventor(s)
      張黎臨、野村富美子、荒木真理人、小松則夫
    • Industrial Property Rights Holder
      張黎臨、野村富美子、荒木真理人、小松則夫
    • Industrial Property Rights Type
      特許
    • Filing Date
      2020
    • Related Report
      2020 Research-status Report
    • Overseas
  • [Patent(Industrial Property Rights)] 非公開2020

    • Inventor(s)
      荒木真理人、小松則夫、木原慶彦
    • Industrial Property Rights Holder
      荒木真理人、小松則夫、木原慶彦
    • Industrial Property Rights Type
      特許
    • Filing Date
      2020
    • Related Report
      2019 Research-status Report
    • Overseas

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi